Metraipolis › archive › dc_6a2de49c082f

Rare disease clinical trials in Italy (2022-May 2026): current trends, future challenges, and the evolving role as reporting member state — Europe PMC PMID:42807533

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42807533
DOI
10.3389/fphar.2026.1934929
License (as archived)
solo-consultazione
Archived
2026-10-10T02:32:10.935Z
SHA-256 of the archived text
2ca7b4a9babb0fdb876dbe9f298867bd3b20807cd1a8ed47e579d72ccdb46cf7
Stable URL of this page
https://metraipolis.com/documento/dc_6a2de49c082f

How to cite

Rare disease clinical trials in Italy (2022-May 2026): current trends, future challenges, and the evolving role as reporting member state — Europe PMC PMID:42807533 — Europe PMC (en), https://europepmc.org/article/MED/42807533 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6a2de49c082f (Metraipolis archive dc_6a2de49c082f, sha256 2ca7b4a9babb0fdb876dbe9f298867bd3b20807cd1a8ed47e579d72ccdb46cf7)
BibTeX
@misc{dc6a2de49c082f,
  title = {Rare disease clinical trials in Italy (2022-May 2026): current trends, future challenges, and the evolving role as reporting member state — Europe PMC PMID:42807533},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42807533},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6a2de49c082f; sha256 2ca7b4a9babb0fdb876dbe9f298867bd3b20807cd1a8ed47e579d72ccdb46cf7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42807533. Agents can read the archived copy with the MCP tool read_document.